Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone in adult septic shock (HyStOON)
NCT01817153Phase 3Terminated
- Sponsor
- Centre Hospitalier Régional d'Orléans
- Start
- Nov 2013
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in septic shock, sponsored by Centre Hospitalier Régional d'Orléans. Started Nov 2013; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01817153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817153.